HUTCHMED (China) HCM
NASDAQ HCM
$12.56 -0.03 (-0.24%)
At close: Aug 20, 2026 · 2:40 PM UTC

HUTCHMED (China) (HCM) EBIT Margin Growth (3y) (2018 - 2021)

HUTCHMED (China) (HCM) EBIT Margin Growth (3y) (2018 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - -
2 Teva Pharmaceutical Industries 43.08 Bn 39.43 Bn 2.15 Bn 1,129.00
3 Zoetis 31.54 Bn 29.87 Bn 1.05 Bn 2.00
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn 59.00
5 United Therapeutics 22.12 Bn 19.46 Bn 683.80 Mn -1,031.00
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -925.00
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn -46.00
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn 6,666.00
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 HUTCHMED (China) 2.17 Bn 2.17 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 26,056.00
Mar 31, 2021 32,653.00
Jun 30, 2019 -28,753.00
Jun 30, 2018 9,863.00